The consortium consists of 13 academic and corporate expert teams from 7 European countries:

Technische Universität Berlin (TUB)  –  Coordinator

CNM-Technologies GmbH (CNMT)

enablingMNT, The Netherlands (e-NL)

Fraunhofer Institute for Micro-electronic Circuits & Systems (IMS)

Mercene Labs AB (ML)

Micropathology Ltd. (MIC)

Radboud University Medical Center (RUMC)

SignalGeneriX Ltd. (SG)

Friedrich-Schiller-Universität Jena (FSU)

Hospital Clínico Universitario de Santiago de Compostela (CHUS)

memsOP Consulting (mOP)

enablingMNT GmbH (e-D)

APTARION biotech AG (AON), as of 1st April 2017

(NOXXON Pharma AG (NOX), participation terminated by 15th March 2017)